Editorial: Integrin Ligands and Their Bioconjugate Systems: Synthesis, Conformation, and Biological Activity.

Front Chem

Organic, Biomolecular and Translational Chemistry, Department of Chemistry, University of Bielefeld, Bielefeld, Germany.

Published: June 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244536PMC
http://dx.doi.org/10.3389/fchem.2022.954618DOI Listing

Publication Analysis

Top Keywords

editorial integrin
4
integrin ligands
4
ligands bioconjugate
4
bioconjugate systems
4
systems synthesis
4
synthesis conformation
4
conformation biological
4
biological activity
4
editorial
1
ligands
1

Similar Publications

Introduction: In recent years, advancements in technology and the refinement of engineering techniques have facilitated the development of tissue engineering, placing particular emphasis on the use of 3D-biomaterials with several structural and chemical geometric features. In particular, increasing information on biomaterial geometric surfaces has allowed for a better understanding of tissue regenerative processes. In the present study a comparison between BioRipar, bovine pericardium membrane, modified with micrometric roundish regular open pores (BioR-Ps) and BioRipar without pores (BioR-NPs) has been investigated.

View Article and Find Full Text PDF

The introduction of tumor necrosis factor inhibitors has led to a paradigm shift in the management of inflammatory bowel disease (IBD). The subsequent introduction of both anti-integrins and cytokine blockers has since expanded the biologic armamentarium. However, immunogenicity, defined as the production of anti-drug antibodies (ADAs) to the prescribed biopharmaceutical, means a significant fraction of patients exposed to biologic agents will experience a secondary loss of response to one or more of the drugs.

View Article and Find Full Text PDF

Mechanosensory entities and functionality of endothelial cells.

Front Cell Dev Biol

October 2024

Faculty of Physics and Earth System Science, Peter Debye Institute of Soft Matter Physics, Biological Physics Division, Leipzig University, Leipzig, Germany.

The endothelial cells of the blood circulation are exposed to hemodynamic forces, such as cyclic strain, hydrostatic forces, and shear stress caused by the blood fluid's frictional force. Endothelial cells perceive mechanical forces via mechanosensors and thus elicit physiological reactions such as alterations in vessel width. The mechanosensors considered comprise ion channels, structures linked to the plasma membrane, cytoskeletal spectrin scaffold, mechanoreceptors, and junctional proteins.

View Article and Find Full Text PDF
Article Synopsis
  • Neutrophils use β-integrins to migrate to inflammation sites with low oxygen and high cytokine levels, and inhibiting prolyl hydroxylase domain-containing enzymes (PHDs) is thought to activate the HIF pathway in these cells.
  • In experiments using PHD inhibitors or hypoxic conditions, researchers found that HIF1α protein accumulation occurs in adherent neutrophils, but not in suspended ones, highlighting the necessity of β-integrins for this process.
  • The study revealed that β-integrins not only promote HIF1α mRNA translation through key factors, but also that activating HIF1α can delay neutrophil apoptosis, suggesting a vital role for this pathway in neutrophil survival
View Article and Find Full Text PDF

The novel anthraquinone compound Kanglexin prevents endothelial-to-mesenchymal transition in atherosclerosis by activating FGFR1 and suppressing integrin β1/TGFβ signaling.

Front Med

December 2024

Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Endothelial-mesenchymal transition (EndMT) disrupts vascular endothelial integrity and induces atherosclerosis. Active integrin β1 plays a pivotal role in promoting EndMT by facilitating TGFβ/Smad signaling in endothelial cells. Here, we report a novel anthraquinone compound, Kanglexin (KLX), which prevented EndMT and atherosclerosis by activating MAP4K4 and suppressing integrin β1/TGFβ signaling.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!